Japanese Surveillance Systems and Treatment for Influenza. - Wikidata - wikimedia - TriplyDB

Japanese Surveillance Systems and Treatment for Influenza.

Japanese Surveillance Systems and Treatment for Influenza.

http://www.wikidata.org/entity/Q30239895

about

The safety and efficacy of quadrivalent live attenuated influenza vaccine in Japanese children aged 2-18 years: Results of two phase 3 studies.

P2860

Q53835317-524AB82C-AAB9-4920-A430-5E06FCBA800A

P2860

Japanese Surveillance Systems and Treatment for Influenza.

http://www.wikidata.org/entity/Q30239895

description

2016 nî lūn-bûn

@nan

2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Japanese Surveillance Systems and Treatment for Influenza.

@ast

Japanese Surveillance Systems and Treatment for Influenza.

@en

type

label

Japanese Surveillance Systems and Treatment for Influenza.

@ast

Japanese Surveillance Systems and Treatment for Influenza.

@en

prefLabel

Japanese Surveillance Systems and Treatment for Influenza.

@ast

Japanese Surveillance Systems and Treatment for Influenza.

@en

P1433

Q30239895-CFB28E27-3813-4200-8F5F-7064556E5D8B

P1476

Q30239895-80DF4FE6-08B0-4F39-8B0B-BDEACA7AC6B7

P2093

Q30239895-5B3AFA4B-8780-43F0-BE11-9E531752E39E

Q30239895-BD5E0F3E-22E8-4793-9D02-B7C1F7626A09

P2860

Q30239895-0585B95E-CA8C-4884-B95F-C465A0ECA777

Q30239895-061D000F-CCA1-477F-88B7-CF02A8591131

Q30239895-07DB5A72-55FA-4EF8-927F-E604C408B5B2

Q30239895-08647405-6736-418A-ACFC-5896A61252D6

Q30239895-0AFCAE83-FEFB-40D4-910F-F1FA7D59ECA5

Q30239895-11715779-83DF-4923-9C74-DD7A71A0310D

Q30239895-15526717-1890-4BD0-8441-459C1BA2EB64

Q30239895-18B4DACF-1F9A-4438-82BA-2054DEA9743D

Q30239895-1ECC7809-C575-48CD-AB4B-D8438C2043D6

Q30239895-1ECFF881-344C-48BC-94AD-1A35058F7A36

P2888

Q30239895-B7D6F131-9E10-40E2-8D5B-C199A7C8AE57

P304

Q30239895-399BE05D-6A7F-443C-9667-B821482C1FA9

P31

Q30239895-98300BC5-08FE-4A15-9F72-E4766B8B75C4

P356

Q30239895-E71A083F-AA76-45F8-B8F6-314FCB192408

P433

Q30239895-F8F6F7D1-8E0D-4E5E-B09D-CCEECEAE147C

P478

Q30239895-8C9C59B1-D118-44AD-A33F-F0209CADF902

P577

Q30239895-9BFEFC37-49BF-47EE-A783-88BF0F2EAA24

P6179

Q30239895-93B3E7F7-3900-404B-8956-167DD39DD533

P698

Q30239895-21E9ADBF-B346-4C4D-A279-026869714630

P932

Q30239895-D387EB52-7DC4-49D6-962F-A55E67328B9C

P356

S40506-016-0085-5

P1433

Current treatment options in infectious diseases

P1476

Japanese Surveillance Systems and Treatment for Influenza.

@en

P2093

Hassan Zaraket

http://www.w3.org/2001/XMLSchema#string

Reiko Saito

http://www.w3.org/2001/XMLSchema#string

P2860

Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections

Widespread use of neuraminidase inhibitors in Japan

The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza

Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers

Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance

Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.

National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic

Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.

In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.

P2888

s40506-016-0085-5

P304

311-328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40506-016-0085-5

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043152044

http://www.w3.org/2001/XMLSchema#string

P698

28035195

http://www.w3.org/2001/XMLSchema#string

P932

5155020

http://www.w3.org/2001/XMLSchema#string